Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott D Cramer

Showing results (11-20 of 58) with videos related to

Pageof 6
Sort By:
The Journal of Biological Chemistry|August 7, 2002
p27Kip1 is essential for the antiproliferative action of 1,25-dihydroxyvitamin D3 in primary, but not immortalized, mouse embryonic fibroblastsWendy N Wade, Mark C Willingham, Constantinos Koumenis, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 19, 2007
A novel mutation in the GRHPR gene in a Japanese patient with primary hyperoxaluria type 2Tatsuya Takayama, Masao Nagata, Seiichiro Ozono, et al.
American Journal of Physiology. Renal Physiology|December 23, 2011
Hydroxyproline metabolism in mouse models of primary hyperoxaluriaJohn Knight, Ross P Holmes, Scott D Cramer, et al.
Cancers|May 13, 2023
Management of Advanced Prostate Cancer in the Precision Oncology EraClaire M Gillette, Gabriel A Yette, Scott D Cramer, et al.
Endocrinology|October 9, 2004
A system for studying epithelial-stromal interactions reveals distinct inductive abilities of stromal cells from benign prostatic hyperplasia and prostate cancerWendy W Barclay, Ralph D Woodruff, M Craig Hall, et al.
Endocrine-Related Cancer|August 21, 2025
Systems biology successes and areas for opportunity in prostate cancerMichael V Orman, Laura S Graham, Scott D Cramer, et al.
Journal of Virology|March 6, 2015
Changes in Susceptibility to Oncolytic Vesicular Stomatitis Virus during Progression of Prostate CancerNanmeng Yu, Shelby Puckett, Peter A Antinozzi, et al.
The Prostate|June 29, 2010
1,25-dihydroxyvitamin D(3) and PI3K/AKT inhibitors synergistically inhibit growth and induce senescence in prostate cancer cellsLinara S Axanova, Yong Q Chen, Thomas McCoy, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 5, 2008
Association of prostate-specific antigen promoter genotype with clinical and histopathologic features of prostate cancerScott D Cramer, Jielin Sun, S Lilly Zheng, et al.
Frontiers in Pharmacology|May 16, 2024
ProstaMine: a bioinformatics tool for identifying subtype-specific co-alterations associated with aggressiveness in prostate cancerMichael V Orman, Varsha Sreekanth, Teemu D Laajala, et al.
Pageof 6

Showing results (11-20 of 58) with videos related to

Sort By:
Pageof 6
The Journal of Biological Chemistry|August 7, 2002
p27Kip1 is essential for the antiproliferative action of 1,25-dihydroxyvitamin D3 in primary, but not immortalized, mouse embryonic fibroblastsWendy N Wade, Mark C Willingham, Constantinos Koumenis, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 19, 2007
A novel mutation in the GRHPR gene in a Japanese patient with primary hyperoxaluria type 2Tatsuya Takayama, Masao Nagata, Seiichiro Ozono, et al.
American Journal of Physiology. Renal Physiology|December 23, 2011
Hydroxyproline metabolism in mouse models of primary hyperoxaluriaJohn Knight, Ross P Holmes, Scott D Cramer, et al.
Cancers|May 13, 2023
Management of Advanced Prostate Cancer in the Precision Oncology EraClaire M Gillette, Gabriel A Yette, Scott D Cramer, et al.
Endocrinology|October 9, 2004
A system for studying epithelial-stromal interactions reveals distinct inductive abilities of stromal cells from benign prostatic hyperplasia and prostate cancerWendy W Barclay, Ralph D Woodruff, M Craig Hall, et al.
Endocrine-Related Cancer|August 21, 2025
Systems biology successes and areas for opportunity in prostate cancerMichael V Orman, Laura S Graham, Scott D Cramer, et al.
Journal of Virology|March 6, 2015
Changes in Susceptibility to Oncolytic Vesicular Stomatitis Virus during Progression of Prostate CancerNanmeng Yu, Shelby Puckett, Peter A Antinozzi, et al.
The Prostate|June 29, 2010
1,25-dihydroxyvitamin D(3) and PI3K/AKT inhibitors synergistically inhibit growth and induce senescence in prostate cancer cellsLinara S Axanova, Yong Q Chen, Thomas McCoy, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 5, 2008
Association of prostate-specific antigen promoter genotype with clinical and histopathologic features of prostate cancerScott D Cramer, Jielin Sun, S Lilly Zheng, et al.
Frontiers in Pharmacology|May 16, 2024
ProstaMine: a bioinformatics tool for identifying subtype-specific co-alterations associated with aggressiveness in prostate cancerMichael V Orman, Varsha Sreekanth, Teemu D Laajala, et al.
Pageof 6